

Bioventus (NASDAQ:BVS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Bioventus (NASDAQ:BVS) through any online brokerage.
Other companies in Bioventus’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
Bioventus has a consensus price target of $14.71.
The stock price for Bioventus (NASDAQ: BVS) is $11.66 last updated November 4, 2026 at 1:13 PM EST.
There are no upcoming dividends for Bioventus.
Bioventus does not have any upcoming earnings scheduled.
There is no upcoming split for Bioventus.
Bioventus is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product...